Therapies for rheumatic disease such immunosuppressants, non-IL-6 biologics, and JAK inhibitors should be stopped temporarily for patients who are exposed to COVID19, according to new guidance issued by the American College of Rheumatology. And in the case of documented or presumptive COVID-19 infection all rheumatic disease treatment except for hydroxychloroquine and possibly IL-6 inhibitors should ...
Stop arthritis treatments in patients exposed to coronavirus, ACR advises
By Michael Woodhead
21 Apr 2020